Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
AIM ImmunoTech Inc (AIM)
NYSE MKT:AIM
Holding AIM?
Track your performance easily
AIM ImmunoTech (AIM) Ownership Overview
3.77% Insiders
3.67% Mutual Funds
7.09% Other Institutional Investors
3.03% ETFs
82.44% Public Companies and
Individual Investors
The ownership structure of AIM ImmunoTech (AIM) stock is a mix of institutional, retail, and individual investors. Approximately 13.79% of the company’s stock is owned by Institutional Investors, 3.77% is owned by Insiders, and 82.44% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| Nov 21, 2024 | Thomas Equels Ceo & President,director | xxxxxxxxxxxxx | $16150 |
| Nov 21, 2024 | Stewart Appelrouth Director | xxxxxxxxxxxxx | $15571 |
| Nov 20, 2024 | Thomas Equels Ceo & President,director | xxxxxxxxxxxxx | $10820 |
| Sep 17, 2024 | Thomas Equels Ceo & President,director | xxxxxxxxxxxxx | $1500 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 1,931,828 | Institution | 3.03% | 407,616 | |
| 1,931,828 | Institution | 3.03% | 407,616 | |
| 1,637,968 | Insider | 2.57% | 345,611 | |
| 401,262 | Insider | 0.63% | 84,666 | |
| 355,924 | Institution | 0.56% | 75,100 | |
| 321,752 | Insider | 0.51% | 67,890 | |
| 43,668 | Institution | 0.07% | 9,214 | |
| 38,462 | Insider | 0.06% | 8,115 | |
| 5,279 | Institution | <0.01% | 1,114 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 1,931,828 | Institution | 3.03% | 407,616 | |
| 355,924 | Institution | 0.56% | 75,100 | |
| 43,668 | Institution | 0.07% | 9,214 | |
| 5,279 | Institution | <0.01% | 1,114 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 1,311,599 | Institution | 2.06% | 340,885 | |
| 620,229 | Institution | 0.97% | 161,198 |
FAQ
Who Owns AIM ImmunoTech Inc (AIM)?
According to the latest TipRanks data, approximately 7.09% of the company's stock is held by institutional investors, 3.77% is held by insiders, and 82.44% is held by retail investors.
What percentage of AIM ImmunoTech Inc (AIM) stock is held by institutional investors?
According to the latest TipRanks data, approximately 7.09% of AIM ImmunoTech Inc (AIM) stock is held by institutional investors.
What percentage of AIM ImmunoTech Inc (AIM) stock is held by retail investors?
According to the latest TipRanks data, approximately 82.44% of AIM ImmunoTech Inc (AIM) stock is held by retail investors.
Who owns the most shares of AIM ImmunoTech Inc (AIM)?
Vanguard owns the most shares of AIM ImmunoTech Inc (AIM).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.